Biotech Showcase

Save up to $400 by November 13! Discount expires in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
January 11–13, 2027 | San Francisco, CA
January 19–20, 2027 | Digital Partnering
Save up to $400 by November 13
Menu
Register

What to expect at Biotech Showcase?

Biotech Showcase, along with its dedicated program and presentation tracks, unites a diverse spectrum of companies, spanning from early-stage ventures to mid and later-stage companies.

Download 2026 list of participating companiesView 2026 presenting companies

Here's what you can expect at Biotech Showcase

Supercharge your 2027 fundraising efforts by connecting with top-tier investors and life science leaders across the entire life science value chain.

With a single registration, not only can you participate in the Biotech Showcase, but you'll also gain access to its specialized showcases: Seed Showcase and DigiMed Showcase. All conveniently housed under one roof.

Investor funding across funding stage

See the breakdown of where biotech investors are focusing their attention across funding stages, from Seed to Post-IPO.

Investor type breakdown

Take a look at the range of investor types engaging with biotech opportunities, from venture capital firms to individual and institutional backers.

Attendee Profile

Biotech Showcase welcomes a diverse spectrum of companies, spanning from seed-stage startups to small- and mid-cap private and public biotech and pharmaceutical firms at various stages of development.

Industry
Sector
Region

Anton Gopka

Managing Partner,

ATEM Capital

As a long-time attendee of the Biotech Showcase … the conference consistently presents outstanding investment opportunities, but this year set a new standard. The blend of innovative startups and established biotech leaders was particularly striking, highlighting the dynamic growth of the sector. The quality of the presentations and the potential for groundbreaking advancements stood out. The event's organization facilitated effective networking, reaffirming its status as an essential event for seasoned investors in life sciences.